Health
AstraZeneca-Oxford COVID-19 Vaccine to be Tested on Children of Age Group 6 to 17 Years for the First Time – LatestLY
The University of Oxford has initiated the process the COVID-19 vaccine it developed in collaboration with drug maker AstraZeneca on children as well. It marks…
London, February 13: The University of Oxford has initiated the process the COVID-19 vaccine it developed in collaboration with drug maker AstraZeneca on children as well. It marks the first the vaccine against coronavirus will be used on children. The trial is being undertaken to study the vaccine’s impact and efficacy on people between age the of 6 to 17.As per reports, the test will be conducted on around 300 children. It is expected to start by the end of this month.
While most children are…
-
Noosa News22 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
General23 hours agoInternal Revenue Service starts cutting 20,000 workers
-
Noosa News23 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland
-
Business23 hours agoWhy last week’s market selloff is a gift for beginner ASX investors